Harrow Health (HROWL) Stock Analysis
NASDAQHealthcareMedical - Pharmaceuticals
What Harrow Health does
Harrow, Inc. is a pharmaceutical company that specializes in the development, production, and distribution of innovative medications. Its business activities are primarily divided into two segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding division notably encompasses the operations of the ImprimisRx business. Co-founded by Mark L. Baum and Robert J. Kammer in January 2006, the firm maintains its corporate headquarters in Nashville, Tennessee.
Key metrics
ETFs linked to HROWL
Broad-market and Healthcare sector ETFs an investor holding Harrow Health is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how HROWL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze HROWL in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Harrow Health?
- Harrow Health trades under the ticker HROWL on NASDAQ.
- Which exchange is HROWL listed on?
- HROWL is listed on NASDAQ.
- What sector does Harrow Health operate in?
- Harrow Health is classified in the Healthcare sector (Medical - Pharmaceuticals industry).
- How can PortView help analyze HROWL in a portfolio?
- PortView shows HROWL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.